Introduction Factors that affect resuscitation to a perfusing rhythm (ROSC) following ventricular fibrillation (VF) include untreated VF duration, acute myocardial infarction (AMI), and possibly factors reflected in the VF waveform. We hypothesized that resuscitation of VF to ROSC within 3 min is predicted by the VF waveform, independent of untreated VF duration or presence of acute MI. Methods AMI was induced by the occlusion of the left anterior descending coronary artery. VF was induced in normal (N = 30) and AMI swine (N = 30). Animals were resuscitated after untreated VF of brief (2 min) or prolonged (8 min) duration. VF waveform was analyzed before the first shock to compute the amplitude-spectral area (AMSA) and slope. Results Unadjusted predictors of ROSC within 3 min included untreated VF duration (8 min vs 2 min; OR 0.11, 95%CI 0.02–0.54), AMI (AMI vs normal; OR 0.11, 95%CI 0.02–0.54), AMSA (highest to lowest tertile; OR 15.5, 95%CI 1.7–140), and slope (highest to lowest tertile; OR 12.7, 95%CI 1.4–114). On multivariate regression, untreated VF duration (P = 0.011) and AMI (P = 0.003) predicted ROSC within 3 min. Among secondary outcome variables, favorable neurological status at 24 h was only predicted by VF duration (OR 0.22, 95% CI 0.05–0.92). Conclusions In this swine model of VF, untreated VF duration and AMI were independent predictors of ROSC following VF cardiac arrest. AMSA and slope predicted ROSC when VF duration or the presence of AMI were unknown. Importantly, the initial treatment of choice for short duration VF is defibrillation regardless of VF waveform.
Currently one of the greatest obstacles facing effective anticancer molecular therapies is efficient drug delivery. Advanced methods such as carriers, liposomes, ultrasound, and viruses have generated modest results with unresolved technical, economical, and regulatory problems. Conventional therapies such as radiation and chemotherapy carry a host of undesirable side effects. Electroporation therapy (EPT) is a promising new modality of drug delivery that exploits the physical process of inducing transient permeability in biological membranes in vivo by short pulses of electric fields. The EPT procedure involves injecting a low dose of drug into cancerous tissue followed by inserting a small needle array that delivers a series of short electrical pulses to induce cellular uptake. In clinical studies EPT has been effective in the treatment of subcutaneous solid tumors of the head and neck, as well as other types of solid tumors when applied with the cytotoxin bleomycin. The utility of EPT has not yet been demonstrated as an adjunct to surgical resection as a potential treatment of wound margins with the aim of reducing tumor recurrence rates. To determine the compatibility of bleomycin-EPT with healing of the surgical wound we studied myocutaneous wound healing in a healthy (noncancerous) porcine model. A series of longitudinal incisions were made along the dorsum of pigs to a depth of 5 mm into the muscle. The margins of each incision were either injected with bleomycin, vehicle (saline), or nothing and two groups received bleomycin or saline, respectively, followed by electroporation (EP). One group received transverse incisions, which were treated with bleomycin-EPT. Wounds were allowed to heal for 2, 7, 14, or 21 days prior to sacrifice and specimens of the incision sites, including skin and muscle, were excised for histological examination. Separate full-thickness skin specimens from across the incision sites were excised and tested for mechanical strength. EP alone showed no significant effect on the mechanical strength of healing porcine skin at any time point. Bleomycin, regardless of use of EP, inhibited the early (< 7 days) development of wound strength; this was most likely due to interference in chemotaxis and/or proliferation of cells involved in early wound healing. However, after 14 days, breaking strength was comparable to saline injected controls. Wound strength after treatment with bleomycin-EPT was higher for longitudinal incisions than for transverse incisions. Histological data documenting the healing process for skin and muscle during the 3 weeks following incision and treatment will be presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.